JDRF Awards $9 Million for Phase 3 Type 1 Diabetes Kidney Disease Clinical Trial, Joins The Kidney Foundation of Canada in Driving Research to Treat Kidney Disease
January 23, 2024
January 23, 2024
NEW YORK, Jan. 23 -- JDRF, a non-profit dedicated to funding type 1 diabetes research, issued the following news release:
New York and Montreal - JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, has awarded $9 million to researchers Dr. Alessandro Doria with Joslin Diabetes Center, Dr. Michael Mauer with the University of Minnesota Medical School, and Dr. David Cherney at the University Health Network, University of Toronto, to conduct a pivotal cli . . .
New York and Montreal - JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, has awarded $9 million to researchers Dr. Alessandro Doria with Joslin Diabetes Center, Dr. Michael Mauer with the University of Minnesota Medical School, and Dr. David Cherney at the University Health Network, University of Toronto, to conduct a pivotal cli . . .